Eleven Biotherapeutics, Inc. 4
4 · Eleven Biotherapeutics, Inc. · Filed Feb 16, 2017
Insider Transaction Report
Form 4
MCCABE JOHN J
Senior Vice President, Finance
Transactions
- Sale
Common Stock
2017-02-14$2.10/sh−1,399$2,938→ 5,930 total
Footnotes (1)
- [F1]The shares of common stock underlying the restricted stock units reported as disposed herein were sold by the issuer in satisfaction of tax withholding obligations associated with the vesting of such units.